- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharma
Novo Nordisk A/S+ Add to Watchlist
NVO:US45.9600 USD 0.2900 0.63%
As of 20:04:07 ET on 08/29/2014.
Company Profile for Novo Nordisk A/S (NVO)
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
Novo Nordisk A/S
Key Executives for Novo Nordisk A/S (NVO)
|Lars Rebien SorensenChief Executive Officer||Kare SchultzPresident/COO|
|Jesper BrandgaardExec VP/CFO||Lars Fruergaard JorgensenExec VP/CIO|
|Mads Krogsgaard ThomsenExec VP/Chief Science Officer||Lise KingoExec VP/Chief of Staffs|
|Jakob RiisExec VP||Kasper Roseeuw PoulsenVP/Head:Investor Relations|